PTEN: A promising pharmacological target to enhance epithelial wound healing

British Journal of Pharmacology

Volumn 152, Issue 8, 2007, Pages 1141-1144

  Zhao, M ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt protein kinase B; Bisperoxovanadium compounds; Cell migration; Epithelium; PI3 kinase; PTEN; Wound healing

Indexed keywords

DIPOTASSIUM BISPEROXO (PICOLINATO) OXOVANADATE; PHOSPHATE; PHOSPHATIDYLINOSITOL (3,4,5) TRIPHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POTASSIUM BISPEROXO (1,10 PHENANTHROLINE) OXOVANADATE; PROTEIN KINASE B; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

CELL MIGRATION; CELL POLARITY; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TISSUE GROWTH; WOUND HEALING;

DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 36949031937     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707503     Document Type: Review

References (24)

1. Block ER, Matela AR, SundarRaj N, Iszkula ER, Klarlund JK (2004). Wounding induces motility in sheets of corneal epithelial cells through loss of spatial constraints: role of heparin-binding epidermal growth factor-like growth factor signaling. J Biol Chem 279: 24307-24312.
2. Comer FI, Parent CA (2007). Phosphoinositides specify polarity during epithelial organ development. Cell 128: 239-240.
3. Cully M, You H, Levine AJ, Mak TW(2006). Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184-192.
4. Engelman JA, Luo J, Cantley LC (2006). The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
5. Huttenlocher A, Horwitz AR (2007). Wound healing with electric potential. N Engl J Med 356: 303-304.
6. Iijima M, Huang YE, Devreotes P (2002). Temporal and spatial regulation of chemotaxis. Dev Cell 3: 469-478.
7. Lai JP, Dalton JT, Knoell DL (2007). Phosphatase and Tensin homolog deleted on chromosome Ten (PTEN) as a Molecular target in lung epithelial wound repair. Br J Pharmacol 152: 1172-1184 (this issue).
8. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y et al. (1999). Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: 323-334.
9. Leslie NR, Yang X, Downes CP, Weijer CJ (2007). PtdIns(3,4,5)P(3)- dependent and -independent roles for PTEN in the control of cell migration. Curr Biol 17: 115-125.
10. Maier D, Jones G, Li X, Schonthal AH, Gratzl O, Van Meir EG et al. (1999). The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 59: 5479-5482.
11. Mocanu MM, Yellon DM (2007). PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol 150: 833-838.
12. Okumura K, Zhao M, Depinho RA, Furnari FB, Cavenee WK (2005). Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor. Proc Natl Acad Sci USA 102: 2703-2706.
13. Pankow S, Bamberger C, Klippel A, Werner S (2006). Regulation of epidermal homeostasis and repair by phosphoinositide 3-kinase. J Cell Sci 119: 4033-4046.
14. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A (2004). Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303: 1179-1181.
15. Rosivatz E (2007). Inhibiting PTEN. Biochem Soc Trans 35: 257-259.
16. Rosivatz E, Matthews JG, McDonald NQ, Mulet X, Ho KK, Lossi N et al. (2006). A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN). ACS Chem Biol 1: 780-790.
17. Schmid AC, Byrne RD, Vilar R, Woscholski R (2004). Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett 566: 35-38.
18. Shimabukuro DW, Sawa T, Gropper MA (2003). Injury and repair in lung and airways. Crit Care Med 31: S524-S531.
19. Tsugawa K, Jones MK, Akahoshi T, Moon WS, Maehara Y, Hashizume M et al. (2003). Abnormal PTEN expression in portal hypertensive gastric mucosa: a key to impaired PI 3-kinase/Akt activation and delayed injury healing? FASEB J 17: 2316-2318.
20. Vanhaesebroeck B (2006). Charging the batteries to heal wounds through PI3K. Nat Chem Biol 2: 453-455.
21. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T et al. (2001). The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol 3: 1124-1128.
22. Xu KP, Yu FS (2007). Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing. Invest Ophthalmol Vis Sci 48: 2242-2248.
23. Yin J, Xu K, Zhang J, Kumar A, Yu FS (2007). Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci 120: 815-825.
24. Zhao M, Song B, Pu J, Wada T, Reid B, Tai G et al. (2006). Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN. Nature 442: 457-460.